This federal contract award is for the delivery of Xyosted 100 mg/0.5 ml auto-injectors, placed as a delivery order under contract SPE2DB22D1202|SPE2DB25FUKC2 with the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,831.32 and an ultimate completion date of November 20, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). This contract is not designated with a set-aside. As a large Indefinite Delivery Contract (IDC) holder with the DLA, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, valued at up to $999,999,999 through November 2026. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.
Generated 2/18/25, 1:34 PM